GI
CLPT icon

GAMMA Investing’s ClearPoint Neuro CLPT Stock Holding History

GAMMA Investing’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.71K Buy
432
+161
+59% +$2.01K ﹤0.01% 3311
2026
Q1 		$2.47K Buy
271
+38
+16% +$480 ﹤0.01% 3596
2025
Q4 		$3.19K Buy
233
+162
+228% +$3K ﹤0.01% 3455
2025
Q3 		$1.55K Buy
+71
New +$836 ﹤0.01% 3516
2024
Q3 		– Sell
-42
Closed -$226 – 3602
2024
Q2 		$226 Hold
42
– – ﹤0.01% 3307
2024
Q1 		$286 Hold
42
– – ﹤0.01% 3189
2023
Q4 		$292 Buy
+42
New +$238 ﹤0.01% 3063

Other funds holding CLPT

CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
CSB
City State Bank Norwalk, Iowa $436M AUM 32.32% 1-Year Est. Return
FMP
Financial Management Professionals Austin, Texas $1.05B AUM 21.07% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
TM
Torren Management San Diego, California $197M AUM
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GAMMA Investing's CLPT Position: Q2 2026 in Review

GAMMA Investing increased its ClearPoint Neuro (CLPT) stake by 59% in Q2 2026, buying an estimated $2.01K and bringing the position to 432 shares worth $7.71K. The position accounts for ﹤0.01% of the portfolio, ranked #3311.

GAMMA Investing first reported a position in CLPT in Q4 2023 and has held it in 7 quarters since. 9 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • GAMMA Investing held 432 shares of ClearPoint Neuro worth $7.71K as of Q2 2026.
  • GAMMA Investing bought 161 ClearPoint Neuro shares in Q2 2026, an estimated $2.01K.
  • ClearPoint Neuro made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3311 holding.
  • GAMMA Investing first reported a position in ClearPoint Neuro in Q4 2023 and has held it in 7 quarters since.
  • 9 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.